Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dilute Bleach Compresses for Radiation Dermatitis in Pediatric Sarcoma
NCT04851522Phase 1Withdrawn
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jun 2021
- Primary completion
- Apr 2022
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of sodium hypochlorite in radiation dermatitis, sponsored by Dana-Farber Cancer Institute. Primary endpoint: Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE Version 5.0 at 1 year. Planned start Jun 2021; status: withdrawn.
02
Drugs
sodium hypochlorite
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT04851522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04851522.